tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market
Want to see SVA full AI Analyst Report?

Sinovac Biotech (SVA) Financial Statements

137 Followers

Sinovac Biotech Financial Overview

Sinovac Biotech's market cap is currently $460.27M. The company's EPS TTM is $-1; its P/E ratio is -7.80; Sinovac Biotech is scheduled to report earnings on June 5, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 386.01M$ 448.27M$ 1.49B$ 19.37B$ 510.62M
Gross Profit$ 261.98M$ 266.75M$ 808.30M$ 18.30B$ 443.44M
Operating Income$ -291.32M$ -546.72M$ -466.07M$ 17.55B$ 215.64M
EBITDA$ -187.66M$ -6.03M$ 183.10M$ 17.65B$ 221.76M
Net Income$ -59.68M$ -99.92M$ 113.87M$ 8.47B$ 110.37M
Balance Sheet
Cash & Short-Term Investments$ 6.64B$ 11.22B$ 11.31B$ 13.42B$ 1.18B
Total Assets$ 8.64B$ 13.66B$ 14.11B$ 16.75B$ 1.90B
Total Debt$ 506.97M$ 298.98M$ 74.67M$ 144.91M$ 136.39M
Net Debt$ -649.46M$ -971.15M$ -4.20B$ -11.46B$ -904.62M
Total Liabilities$ 2.23B$ 1.64B$ 1.40B$ 2.87B$ 781.20M
Stockholders' Equity$ 4.44B$ 8.71B$ 8.92B$ 9.33B$ 746.47M
Cash Flow
Free Cash Flow$ -559.40M$ -41.69M$ -1.17B$ 14.63B$ 351.66M
Operating Cash Flow$ -510.49M$ 104.00M$ -770.75M$ 15.35B$ 479.31M
Investing Cash Flow$ 4.39B$ -2.93B$ -5.76B$ -3.02B$ -204.76M
Financing Cash Flow$ -3.43B$ -76.06M$ -241.40M$ -1.90B$ 592.57M
Currency in USD

Sinovac Biotech Earnings and Revenue History

Sinovac Biotech Debt to Assets

Sinovac Biotech Cash Flow

Sinovac Biotech Forecast EPS vs Actual EPS